 | • レポートコード：QYR2104Z1068 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん分子バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遺伝的手法、タンパク質手法、画像）、用途別市場規模（製薬会社、医療研究所、病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん分子バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・がん分子バイオマーカーの種類別市場規模（遺伝的手法、タンパク質手法、画像） ・がん分子バイオマーカーの用途別市場規模（製薬会社、医療研究所、病院） ・がん分子バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・がん分子バイオマーカーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん分子バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん分子バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・がん分子バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Correlogic Systems、AgendiaBv、BioMerieux、Aureon Laboratories、Astellas Pharma US、Becton、Diadexus、Abbott Laboratories、Affymetrix、Clarient、Biomoda、Beckman Coulter、Dickinson） ・結論 |
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments.
Factors such as technological advancements, increasing research and development activities, increase in funding from various government and non-government organizations, rise in healthcare expenditure, non invasive technology, increasing incidences of cancer, and streamlined drug delivery process are expected to drive the market for cancer molecular biomarkers .In addition, growing survival rates and increased accuracy of diagnosis with the help of biomarkers are expected to drive market for cancer molecular biomarkers.
Market Analysis and Insights: Global Cancer Molecular Biomarkers Market
The global Cancer Molecular Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Molecular Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Molecular Biomarkers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Molecular Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Molecular Biomarkers market.
Global Cancer Molecular Biomarkers Scope and Market Size
Cancer Molecular Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Molecular Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Genetic Methods
Protein Methods
Imaging
Segment by Application
Pharmaceutical Companies
Medical Laboratory
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Correlogic Systems
AgendiaBv
BioMerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix
Aureon Laboratories
Astellas Pharma US
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Molecular Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Genetic Methods
1.2.3 Protein Methods
1.2.4 Imaging
1.3 Market by Application
1.3.1 Global Cancer Molecular Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Companies
1.3.3 Medical Laboratory
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Molecular Biomarkers Market Perspective (2016-2027)
2.2 Cancer Molecular Biomarkers Growth Trends by Regions
2.2.1 Cancer Molecular Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Molecular Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Molecular Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Molecular Biomarkers Industry Dynamic
2.3.1 Cancer Molecular Biomarkers Market Trends
2.3.2 Cancer Molecular Biomarkers Market Drivers
2.3.3 Cancer Molecular Biomarkers Market Challenges
2.3.4 Cancer Molecular Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Molecular Biomarkers Players by Revenue
3.1.1 Global Top Cancer Molecular Biomarkers Players by Revenue (2016-2021)
3.1.2 Global Cancer Molecular Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Molecular Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Molecular Biomarkers Revenue
3.4 Global Cancer Molecular Biomarkers Market Concentration Ratio
3.4.1 Global Cancer Molecular Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Molecular Biomarkers Revenue in 2020
3.5 Cancer Molecular Biomarkers Key Players Head office and Area Served
3.6 Key Players Cancer Molecular Biomarkers Product Solution and Service
3.7 Date of Enter into Cancer Molecular Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Molecular Biomarkers Breakdown Data by Type
4.1 Global Cancer Molecular Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global Cancer Molecular Biomarkers Forecasted Market Size by Type (2022-2027)
5 Cancer Molecular Biomarkers Breakdown Data by Application
5.1 Global Cancer Molecular Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global Cancer Molecular Biomarkers Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Molecular Biomarkers Market Size (2016-2027)
6.2 North America Cancer Molecular Biomarkers Market Size by Type
6.2.1 North America Cancer Molecular Biomarkers Market Size by Type (2016-2021)
6.2.2 North America Cancer Molecular Biomarkers Market Size by Type (2022-2027)
6.2.3 North America Cancer Molecular Biomarkers Market Size by Type (2016-2027)
6.3 North America Cancer Molecular Biomarkers Market Size by Application
6.3.1 North America Cancer Molecular Biomarkers Market Size by Application (2016-2021)
6.3.2 North America Cancer Molecular Biomarkers Market Size by Application (2022-2027)
6.3.3 North America Cancer Molecular Biomarkers Market Size by Application (2016-2027)
6.4 North America Cancer Molecular Biomarkers Market Size by Country
6.4.1 North America Cancer Molecular Biomarkers Market Size by Country (2016-2021)
6.4.2 North America Cancer Molecular Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Molecular Biomarkers Market Size (2016-2027)
7.2 Europe Cancer Molecular Biomarkers Market Size by Type
7.2.1 Europe Cancer Molecular Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe Cancer Molecular Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe Cancer Molecular Biomarkers Market Size by Type (2016-2027)
7.3 Europe Cancer Molecular Biomarkers Market Size by Application
7.3.1 Europe Cancer Molecular Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe Cancer Molecular Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe Cancer Molecular Biomarkers Market Size by Application (2016-2027)
7.4 Europe Cancer Molecular Biomarkers Market Size by Country
7.4.1 Europe Cancer Molecular Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe Cancer Molecular Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Molecular Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific Cancer Molecular Biomarkers Market Size by Type
8.2.1 Asia-Pacific Cancer Molecular Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Molecular Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Molecular Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Molecular Biomarkers Market Size by Application
8.3.1 Asia-Pacific Cancer Molecular Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Molecular Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Molecular Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Molecular Biomarkers Market Size by Region
8.4.1 Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Molecular Biomarkers Market Size (2016-2027)
9.2 Latin America Cancer Molecular Biomarkers Market Size by Type
9.2.1 Latin America Cancer Molecular Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Molecular Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Molecular Biomarkers Market Size by Type (2016-2027)
9.3 Latin America Cancer Molecular Biomarkers Market Size by Application
9.3.1 Latin America Cancer Molecular Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Molecular Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Molecular Biomarkers Market Size by Application (2016-2027)
9.4 Latin America Cancer Molecular Biomarkers Market Size by Country
9.4.1 Latin America Cancer Molecular Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Molecular Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Molecular Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa Cancer Molecular Biomarkers Market Size by Type
10.2.1 Middle East & Africa Cancer Molecular Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Molecular Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Molecular Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Molecular Biomarkers Market Size by Application
10.3.1 Middle East & Africa Cancer Molecular Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Molecular Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Molecular Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Molecular Biomarkers Market Size by Country
10.4.1 Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Correlogic Systems
11.1.1 Correlogic Systems Company Details
11.1.2 Correlogic Systems Business Overview
11.1.3 Correlogic Systems Cancer Molecular Biomarkers Introduction
11.1.4 Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.1.5 Correlogic Systems Recent Development
11.2 AgendiaBv
11.2.1 AgendiaBv Company Details
11.2.2 AgendiaBv Business Overview
11.2.3 AgendiaBv Cancer Molecular Biomarkers Introduction
11.2.4 AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.2.5 AgendiaBv Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Cancer Molecular Biomarkers Introduction
11.3.4 BioMerieux Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.3.5 BioMerieux Recent Development
11.4 Aureon Laboratories
11.4.1 Aureon Laboratories Company Details
11.4.2 Aureon Laboratories Business Overview
11.4.3 Aureon Laboratories Cancer Molecular Biomarkers Introduction
11.4.4 Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.4.5 Aureon Laboratories Recent Development
11.5 Astellas Pharma US
11.5.1 Astellas Pharma US Company Details
11.5.2 Astellas Pharma US Business Overview
11.5.3 Astellas Pharma US Cancer Molecular Biomarkers Introduction
11.5.4 Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.5.5 Astellas Pharma US Recent Development
11.6 Becton
11.6.1 Becton Company Details
11.6.2 Becton Business Overview
11.6.3 Becton Cancer Molecular Biomarkers Introduction
11.6.4 Becton Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.6.5 Becton Recent Development
11.7 Diadexus
11.7.1 Diadexus Company Details
11.7.2 Diadexus Business Overview
11.7.3 Diadexus Cancer Molecular Biomarkers Introduction
11.7.4 Diadexus Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.7.5 Diadexus Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Cancer Molecular Biomarkers Introduction
11.8.4 Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Affymetrix
11.9.1 Affymetrix Company Details
11.9.2 Affymetrix Business Overview
11.9.3 Affymetrix Cancer Molecular Biomarkers Introduction
11.9.4 Affymetrix Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.9.5 Affymetrix Recent Development
11.10 Clarient
11.10.1 Clarient Company Details
11.10.2 Clarient Business Overview
11.10.3 Clarient Cancer Molecular Biomarkers Introduction
11.10.4 Clarient Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.10.5 Clarient Recent Development
11.11 Biomoda
11.11.1 Biomoda Company Details
11.11.2 Biomoda Business Overview
11.11.3 Biomoda Cancer Molecular Biomarkers Introduction
11.11.4 Biomoda Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.11.5 Biomoda Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Details
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Cancer Molecular Biomarkers Introduction
11.12.4 Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.12.5 Beckman Coulter Recent Development
11.13 Dickinson
11.13.1 Dickinson Company Details
11.13.2 Dickinson Business Overview
11.13.3 Dickinson Cancer Molecular Biomarkers Introduction
11.13.4 Dickinson Revenue in Cancer Molecular Biomarkers Business (2016-2021)
11.13.5 Dickinson Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Molecular Biomarkers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Genetic Methods
Table 3. Key Players of Protein Methods
Table 4. Key Players of Imaging
Table 5. Global Cancer Molecular Biomarkers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cancer Molecular Biomarkers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Molecular Biomarkers Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cancer Molecular Biomarkers Market Share by Regions (2016-2021)
Table 9. Global Cancer Molecular Biomarkers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cancer Molecular Biomarkers Market Share by Regions (2022-2027)
Table 11. Cancer Molecular Biomarkers Market Trends
Table 12. Cancer Molecular Biomarkers Market Drivers
Table 13. Cancer Molecular Biomarkers Market Challenges
Table 14. Cancer Molecular Biomarkers Market Restraints
Table 15. Global Cancer Molecular Biomarkers Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cancer Molecular Biomarkers Market Share by Players (2016-2021)
Table 17. Global Top Cancer Molecular Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Molecular Biomarkers as of 2020)
Table 18. Ranking of Global Top Cancer Molecular Biomarkers Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cancer Molecular Biomarkers Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Molecular Biomarkers Product Solution and Service
Table 22. Date of Enter into Cancer Molecular Biomarkers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Molecular Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2016-2021)
Table 26. Global Cancer Molecular Biomarkers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cancer Molecular Biomarkers Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cancer Molecular Biomarkers Revenue Market Share by Application (2016-2021)
Table 30. Global Cancer Molecular Biomarkers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cancer Molecular Biomarkers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cancer Molecular Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cancer Molecular Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cancer Molecular Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cancer Molecular Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cancer Molecular Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cancer Molecular Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cancer Molecular Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cancer Molecular Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cancer Molecular Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cancer Molecular Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cancer Molecular Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cancer Molecular Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cancer Molecular Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cancer Molecular Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cancer Molecular Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cancer Molecular Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cancer Molecular Biomarkers Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cancer Molecular Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cancer Molecular Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cancer Molecular Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cancer Molecular Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cancer Molecular Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cancer Molecular Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cancer Molecular Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cancer Molecular Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cancer Molecular Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cancer Molecular Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cancer Molecular Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 62. Correlogic Systems Company Details
Table 63. Correlogic Systems Business Overview
Table 64. Correlogic Systems Cancer Molecular Biomarkers Product
Table 65. Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 66. Correlogic Systems Recent Development
Table 67. AgendiaBv Company Details
Table 68. AgendiaBv Business Overview
Table 69. AgendiaBv Cancer Molecular Biomarkers Product
Table 70. AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 71. AgendiaBv Recent Development
Table 72. BioMerieux Company Details
Table 73. BioMerieux Business Overview
Table 74. BioMerieux Cancer Molecular Biomarkers Product
Table 75. BioMerieux Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 76. BioMerieux Recent Development
Table 77. Aureon Laboratories Company Details
Table 78. Aureon Laboratories Business Overview
Table 79. Aureon Laboratories Cancer Molecular Biomarkers Product
Table 80. Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 81. Aureon Laboratories Recent Development
Table 82. Astellas Pharma US Company Details
Table 83. Astellas Pharma US Business Overview
Table 84. Astellas Pharma US Cancer Molecular Biomarkers Product
Table 85. Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 86. Astellas Pharma US Recent Development
Table 87. Becton Company Details
Table 88. Becton Business Overview
Table 89. Becton Cancer Molecular Biomarkers Product
Table 90. Becton Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 91. Becton Recent Development
Table 92. Diadexus Company Details
Table 93. Diadexus Business Overview
Table 94. Diadexus Cancer Molecular Biomarkers Product
Table 95. Diadexus Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 96. Diadexus Recent Development
Table 97. Abbott Laboratories Company Details
Table 98. Abbott Laboratories Business Overview
Table 99. Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 100. Abbott Laboratories Recent Development
Table 101. Affymetrix Company Details
Table 102. Affymetrix Business Overview
Table 103. Affymetrix Cancer Molecular Biomarkers Product
Table 104. Affymetrix Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 105. Affymetrix Recent Development
Table 106. Clarient Company Details
Table 107. Clarient Business Overview
Table 108. Clarient Cancer Molecular Biomarkers Product
Table 109. Clarient Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 110. Clarient Recent Development
Table 111. Biomoda Company Details
Table 112. Biomoda Business Overview
Table 113. Biomoda Cancer Molecular Biomarkers Product
Table 114. Biomoda Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 115. Biomoda Recent Development
Table 116. Beckman Coulter Company Details
Table 117. Beckman Coulter Business Overview
Table 118. Beckman Coulter Cancer Molecular Biomarkers Product
Table 119. Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 120. Beckman Coulter Recent Development
Table 121. Dickinson Company Details
Table 122. Dickinson Business Overview
Table 123. Dickinson Cancer Molecular Biomarkers Product
Table 124. Dickinson Revenue in Cancer Molecular Biomarkers Business (2016-2021) & (US$ Million)
Table 125. Dickinson Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Molecular Biomarkers Market Share by Type: 2020 VS 2027
Figure 2. Genetic Methods Features
Figure 3. Protein Methods Features
Figure 4. Imaging Features
Figure 5. Global Cancer Molecular Biomarkers Market Share by Application: 2020 VS 2027
Figure 6. Pharmaceutical Companies Case Studies
Figure 7. Medical Laboratory Case Studies
Figure 8. Hospital Case Studies
Figure 9. Cancer Molecular Biomarkers Report Years Considered
Figure 10. Global Cancer Molecular Biomarkers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cancer Molecular Biomarkers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cancer Molecular Biomarkers Market Share by Regions: 2020 VS 2027
Figure 13. Global Cancer Molecular Biomarkers Market Share by Regions (2022-2027)
Figure 14. Global Cancer Molecular Biomarkers Market Share by Players in 2020
Figure 15. Global Top Cancer Molecular Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Molecular Biomarkers as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cancer Molecular Biomarkers Revenue in 2020
Figure 17. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2016-2021)
Figure 18. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2022-2027)
Figure 19. North America Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cancer Molecular Biomarkers Market Share by Type (2016-2027)
Figure 21. North America Cancer Molecular Biomarkers Market Share by Application (2016-2027)
Figure 22. North America Cancer Molecular Biomarkers Market Share by Country (2016-2027)
Figure 23. United States Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Molecular Biomarkers Market Share by Type (2016-2027)
Figure 27. Europe Cancer Molecular Biomarkers Market Share by Application (2016-2027)
Figure 28. Europe Cancer Molecular Biomarkers Market Share by Country (2016-2027)
Figure 29. Germany Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Molecular Biomarkers Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cancer Molecular Biomarkers Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cancer Molecular Biomarkers Market Share by Region (2016-2027)
Figure 39. China Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Molecular Biomarkers Market Share by Type (2016-2027)
Figure 47. Latin America Cancer Molecular Biomarkers Market Share by Application (2016-2027)
Figure 48. Latin America Cancer Molecular Biomarkers Market Share by Country (2016-2027)
Figure 49. Mexico Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Molecular Biomarkers Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cancer Molecular Biomarkers Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cancer Molecular Biomarkers Market Share by Country (2016-2027)
Figure 55. Turkey Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cancer Molecular Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Correlogic Systems Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 59. AgendiaBv Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 60. BioMerieux Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 61. Aureon Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 62. Astellas Pharma US Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 63. Becton Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 64. Diadexus Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 65. Abbott Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 66. Affymetrix Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 67. Clarient Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 68. Biomoda Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 69. Beckman Coulter Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 70. Dickinson Revenue Growth Rate in Cancer Molecular Biomarkers Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界のがんバイオマーカー検出市場規模・現状・予測（2021年-2027年） Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells. Market Analysis and Insights: Global Cancer Biomarkers Detection Market The global Cancer Biomarkers Detection market size is projected to reach US$ XX million by 2027, from US$ XX …- 世界の結腸直腸がん分子診断市場規模・現状・予測（2021年-2027年） Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine…
- 世界の腫瘍学ベース分子診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oncology Based Molecular Diagnostic Market The global Oncology Based Molecular Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…
- 世界の分子イメージング市場規模・現状・予測（2021年-2027年） Molecular imaging originated from the field of radiopharmacology due to the need to better understand fundamental molecular pathways inside organisms in a noninvasive manner. SPECT segment dominated the global molecular imaging market in revenue terms in 2017, and the trend is projected to continue …
- 世界の医療分子画像市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Medical Molecular Imaging Market The global Medical Molecular Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…